1. Home
  2. DEA vs AMPH Comparison

DEA vs AMPH Comparison

Compare DEA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Easterly Government Properties Inc.

DEA

Easterly Government Properties Inc.

SELL

Current Price

$21.81

Market Cap

1.1B

Sector

Real Estate

ML Signal

SELL

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

SELL

Current Price

$25.85

Market Cap

1.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DEA
AMPH
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
DEA
AMPH
Price
$21.81
$25.85
Analyst Decision
Hold
Hold
Analyst Count
7
7
Target Price
★ $25.36
$22.50
AVG Volume (30 Days)
★ 509.2K
479.1K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
★ 8.19%
N/A
EPS Growth
★ 50.00
N/A
EPS
0.08
★ 0.81
Revenue
$336,099,000.00
★ $719,887,000.00
Revenue This Year
$7.51
$3.87
Revenue Next Year
$2.57
$4.90
P/E Ratio
$274.88
★ $32.62
Revenue Growth
★ 11.27
N/A
52 Week Low
$20.56
$16.65
52 Week High
$25.96
$29.52

Technical Indicators

Market Signals
Indicator
DEA
AMPH
Relative Strength Index (RSI) 27.90 54.73
Support Level $21.65 $25.23
Resistance Level $23.74 $29.40
Average True Range (ATR) 0.48 0.86
MACD -0.08 -0.13
Stochastic Oscillator 4.79 27.20

Price Performance

Historical Comparison
DEA
AMPH

About DEA Easterly Government Properties Inc.

Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: